ProfileGDS5678 / 1459269_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 13% 13% 23% 13% 13% 14% 15% 14% 14% 14% 13% 14% 13% 14% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.3595313
GSM967853U87-EV human glioblastoma xenograft - Control 22.335213
GSM967854U87-EV human glioblastoma xenograft - Control 32.5396823
GSM967855U87-EV human glioblastoma xenograft - Control 42.2757313
GSM967856U87-EV human glioblastoma xenograft - Control 52.2792113
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4022714
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4025315
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3224414
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3188314
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.3287114
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.3218313
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3127914
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3306813
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3295814